ABT Stock Chart & Fundamental Analysis

Interactive Chart

About Abbott Laboratories

Name

Abbott Laboratories

CEO

Robert Ford

Website

www.abbott.com

Industry

Healthcare

Year Founded

1888

Employees

114,000

Abbott Laboratories is a healthcare company focused on diagnostics, medical devices, nutrition, and branded generic medicines. Its product offerings range from glucose monitoring systems and cardiovascular devices to infant formula and adult nutrition products. The company’s diagnostics division supplies laboratories and hospitals with testing platforms that support disease detection and management. Abbott also provides branded generics in emerging markets, expanding access to affordable healthcare. With a presence across North America, Europe, Asia, and Latin America, the company operates within the healthcare sector, supporting both developed and developing markets with products designed to improve patient outcomes and quality of life.

Analyst Ratings

Consensus Recommendation

Buy3

Hold6

Sell14

Fundamentals & Financials

Revenue (TTM)

$44.3B

Net Income (TTM)

$6.5B

EPS (TTM)

$3.74

ROA (TTM)

7.52%

Current Ratio

1.58

Dividend Yield

0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q4 2025	Q3 2025	Q2 2025
Revenue	$11,459M	$11,369M	$11,142M
Cost of Sales	$4,922M	$5,031M	$4,854M
Gross Profit	$6,537M	$6,338M	$6,288M
Operating Income	$2,251M	$2,057M	$2,052M
Net Income	$1,776M	$1,644M	$1,779M
EPS	$1.02	$0.94	$1.02

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Abbott Laboratories's Technical Indicators Summary

Abbott Laboratories, near $102.87, shows a clear bearish tilt with a strong downtrend signaled by ADX above 30 and price sitting well below its short, medium and 200‑day moving averages. Momentum measures are weak: RSI is low, MACD is negative, and on‑balance volume is substantially negative, all pointing to selling pressure. Volatility is moderate and the classic pivot sits just under the current price, offering a nearby reference for resistance. Technical takeaway: Bearish profile confirmed by trend strength, momentum and volume, with the pivot area acting as immediate resistance.

Buy

3 signals

Neutral

6 signals

Sell

14 signals

Overall: Bearish61% Bearish signals

Indicator	Value	Signal	Explanation
RSI (14)	33.78	Neutral	RSI (33.78) is neutral.
Stochastic %K (14, 3, 3)	16.03	Buy	Stochastic (16.03) < 20, indicating oversold.
CCI (20)	-98.82	Neutral	CCI (-98.82) is neutral.
WPR (14)	-81.88	Buy	Williams %R (-81.88) < -80, indicating oversold.
Momentum (10)	-4.32	Sell	Momentum (-4.32) is negative.
MFI	15.90	Buy	MFI (15.90) < 20, indicating oversold.
MACD Level (12, 26)	-2.65	Sell	Confirmed downtrend: MACD (-2.65) is negative and below its signal line (-2.37).
Bollinger Bands	$100.08 - $113.22	Neutral	Price is within the bands.
ATR (14)	$2.32 (2.26%)	Neutral	Moderate Volatility (2.26%).
ADX (14)	31.83	Sell	Strong downtrend (ADX > 25) with bearish directional movement. ADX(31.83), +DI(11.06), -DI(31.93)
OBV	-157,358,600	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(-157,358,600), 20D-SMA-OBV(-89,161,760)
Classic Pivot Point	$102.79	Neutral	Price ($102.87) hovering around equilibrium (P: $102.79) — no clear directional bias.
Fibonacci Pivot Point	$102.79	Neutral	Price ($102.87) hovering around equilibrium (P: $102.79) — no clear directional bias.
Exponential Moving Averages	$104.10 - $121.67(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.
Simple Moving Averages	$103.76 - $124.29(5 indicators)	Sell	SMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Into the close, ABT retained a slight positive bias, with the 0.48% gap from yesterday leaving it near 102.87. The tape closed on an exceptionally quiet note for ABT, with volumes at 0.27× the standard pace. ABT nudges higher as Exact Sciences integration widens ABT's oncology diagnostics growth path.

Price Change

from $102.91 close

-$0.04

Trading Volume

Below avg (16.1M)

4.2M

vs S&P 500 Today

Moderate Outperformance

+0.38%

52-Week Position

Near lows

5.2%